^Nusser E, Donath H, Russ W. [On the circulatory action of depot-Effortil in patients with hypotonic regulation circulator disorders]. Die Medizinische Welt. August 1965, 32: 1824–7. PMID 5320529(German). 引文格式1维护:未识别语文类型 (link)
^Mellander S. Comparative effects of acetylcholine, butyl-nor-synephrine (Vasculat), noradrenaline, and ethyl-adrainol (Effonti) on resistance, capacitance, and precapillary sphincter vessels and capillary filtration in cat skeletal muscle. Angiologica. 1966, 3 (2): 77–99. PMID 4380206. doi:10.1159/000157650.
^von Limbourg P, Just H, Lang KF. Positive inotrope Wirkung von Etilefrinhydrochlorid (EffortilR). Kardiol. 1973, 586: 1.
^Tarnow J, Brückner JB, Eberlein HG, Patschke D, Reinecke A, Schmicke P. Experimentelle Untersuchungen zur Beeinflussung der Hämodynamik in tiefer Halothannarkose durch Dopamin, Glucagon, Effortil, Noradrenalin und Dextran. Der Anaesthesist. 1973, 22: 8–15.
^Carrera AL, Aguilera AM. Algunos effectos circulatorios de la m− oxifenil etanol etilmaina y sus modificaciones por el bloqueo α y β adrenergico.. Arch. Inst. Cardiol. (Mexico). 1973, 43: 279–287.
^Offermeier J, Dreyer AC. A comparison of the effects of noradrenaline, adrenaline and some phenylephrine derivatives on alpha-, beta- and beta- adrenergic receptors. South African Medical Journal = Suid-Afrikaanse Tydskrif vir Geneeskunde. March 1971, 45 (10): 265–7. PMID 4396765.